BOLT - Bolt Biotherapeutics GAAP EPS of -$0.43 beats by $0.03 revenue of $2.5M beats by $0.74M
2023-11-09 17:38:54 ET
- Bolt Biotherapeutics press release ( NASDAQ: BOLT ): Q3 GAAP EPS of -$0.43 beats by $0.03 .
- Revenue of $2.5M (+19.0% Y/Y) beats by $0.74M .
- Cash, cash equivalents, and marketable securities were $141.4 million as of September 30, 2023.
- Cash on hand is expected to fund multiple milestones and operations through 2025.
For further details see:
Bolt Biotherapeutics GAAP EPS of -$0.43 beats by $0.03, revenue of $2.5M beats by $0.74M